EUVIMEDEUVIMED entdecken
Open Access

sB7-H4 is a diagnostic biomarker in epithelial ovarian cancer and correlates to platinum resistance

Ying Zhou iD, Jingluan Tian, Yu Shen, Hansi Liang, Youguo Chen, Juan Wang, Yanzheng Gu

Clinical and Experimental Immunology · 2025

DOI: 10.1093/cei/uxae084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Ying Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Jiangsu, China. Hauptthemen laut MEDLINE: V-Set Domain-Containing T-Cell Activation Inhibitor 1, Biomarkers, Tumor, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Suzhou Minsheng Science and Technology, Project of Jiangsu Health Development Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC), with its high mortality rate among gynecological cancers, is often diagnosed late due to the lack of early diagnostic symptoms and biomarkers. The tumor immune microenvironment has become a focal point in cancer diagnostic and therapeutic research. Among these, B7-H4, a checkpoint protein, plays a crucial role in immune regulation and tumor suppression, contributing to immune evasion within the tumor microenvironment. This study aims to identify the concentration of soluble B7-H4(sB7-H4) in the plasma of patients with OC and to evaluate its clinical significance. Through a comprehensive analysis involving enzyme-linked immunosorbent assay, immunohistochemistry, and multicolor immunofluorescence, we quantified sB7-H4 levels in patient plasma and ascites, correlating these findings with tissue expression and clinical outcomes. Results indicated a strong association between high sB7-H4 levels and advanced disease, surgical outcomes, lymphatic metastasis, and platinum resistance. When compared with traditional biomarkers CA125 and HE4, sB7-H4, especially in conjunction with these markers, enhances the diagnostic accuracy for epithelial ovarian cancer (EOC), offering insights into disease progression and therapeutic efficacy. This comprehensive analysis suggests that sB7-H4 is a promising biomarker for EOC, providing valuable insights into diagnosis, stage differentiation, treatment effectiveness, and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

V-Set Domain-Containing T-Cell Activation Inhibitor 1Biomarkers, TumorOvarian NeoplasmsCarcinoma, Ovarian EpithelialDrug Resistance, NeoplasmHumansFemaleMiddle AgedTumor MicroenvironmentCA-125 AntigenAdultAgedPrognosis

Stichwörter der Autor:innen

biomarkerepithelial ovarian cancerimmunotherapyplatinum resistancesoluble B7-H4

Substanzen

V-Set Domain-Containing T-Cell Activation Inhibitor 1Biomarkers, TumorVTCN1 protein, humanCA-125 Antigen

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Jiangsu, China.
  • Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Jiangsu, China.
  • Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, China.

ORCID-Profile: Ying Zhou

Förderung

  • Suzhou Minsheng Science and Technology
  • Project of Jiangsu Health Development Research Center

Zitieren

APA

Zhou, Y., Tian, J., Shen, Y., Liang, H., Chen, Y., Wang, J., & Gu, Y. (2025). sB7-H4 is a diagnostic biomarker in epithelial ovarian cancer and correlates to platinum resistance. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae084

Vancouver

Zhou Y, Tian J, Shen Y, Liang H, Chen Y, Wang J, et al. sB7-H4 is a diagnostic biomarker in epithelial ovarian cancer and correlates to platinum resistance. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxae084

BibTeX
@article{Zhou2025,
  author = {Zhou, Ying and Tian, Jingluan and Shen, Yu and Liang, Hansi and Chen, Youguo and Wang, Juan and Gu, Yanzheng},
  title = {sB7-H4 is a diagnostic biomarker in epithelial ovarian cancer and correlates to platinum resistance},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  doi = {10.1093/cei/uxae084}
}
Kostenlos starten →